| Early assessment of lung cancer immunotherapy response via circulating tumor DNA SB Goldberg, A Narayan, AJ Kole, RH Decker, J Teysir, NJ Carriero, ... Clinical Cancer Research 24 (8), 1872-1880, 2018 | 367 | 2018 |
| Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing A Narayan, NJ Carriero, SN Gettinger, J Kluytenaar, KR Kozak, TI Yock, ... Cancer research 72 (14), 3492-3498, 2012 | 279 | 2012 |
| Serine threonine protein kinases of mycobacterial genus: phylogeny to function A Narayan, P Sachdeva, K Sharma, AK Saini, AK Tyagi, Y Singh Physiological genomics 29 (1), 66-75, 2007 | 110 | 2007 |
| Oligosaccharyltransferase inhibition overcomes therapeutic resistance to EGFR tyrosine kinase inhibitors C Lopez Sambrooks, M Baro, A Quijano, A Narayan, W Cui, P Greninger, ... Cancer research 78 (17), 5094-5106, 2018 | 55 | 2018 |
| PknH, a transmembrane Hank's type serine/threonine kinase from Mycobacterium tuberculosis is differentially expressed under stress conditions K Sharma, H Chandra, PK Gupta, M Pathak, A Narayan, LS Meena, ... FEMS microbiology letters 233 (1), 107-113, 2004 | 48 | 2004 |
| High-throughput RNA profiling via up-front sample parallelization A Narayan, A Bommakanti, AA Patel Nature methods 12 (4), 343-346, 2015 | 22 | 2015 |
| Phenylalanine-rich peptides potently bind ESAT6, a virulence determinant of Mycobacterium tuberculosis, and concurrently affect the pathogen's growth K Kumar, M Tharad, S Ganapathy, G Ram, A Narayan, JA Khan, R Pratap, ... PLoS One 4 (11), e7615, 2009 | 22 | 2009 |
| Spo0B of Bacillus anthracis – a protein with pleiotropic functions AR Mattoo, M Saif Zaman, GP Dubey, A Arora, A Narayan, N Jailkhani, ... The FEBS Journal 275 (4), 739-752, 2008 | 18 | 2008 |
| Loss of kinase activity in Mycobacterium tuberculosis multidomain protein Rv1364c P Sachdeva, A Narayan, R Misra, V Brahmachari, Y Singh The FEBS Journal 275 (24), 6295-6308, 2008 | 16 | 2008 |
| Tumor DNA mutations from intraparenchymal brain metastases are detectable in CSF SK Cheok, A Narayan, A Arnal-Estape, S Gettinger, SB Goldberg, ... Jco Precision Oncology 5, 163-172, 2021 | 14 | 2021 |
| Iodonium-Catalyzed Carbonyl–Olefin Metathesis Reactions G Oss, TV Nguyen Synlett 30 (17), 1966-1970, 2019 | 12 | 2019 |
| Comparative genomic study of spo0E family genes and elucidation of the role of Spo0E in Bacillusáanthracis GP Dubey, A Narayan, AR Mattoo, GP Singh, RK Kurupati, MS Zaman, ... Archives of microbiology 191, 241-253, 2009 | 9 | 2009 |
| Assessing response to immunotherapy in patients with non-small cell lung cancer using circulating tumor DNA SB Goldberg, A Narayan, AJ Kole, RH Decker, J Teysir, NJ Carriero, ... Annals of Oncology 28, v478, 2017 | 3 | 2017 |
| 35. Evaluating Csf Circulating Tumor DNA in Intraparenchymal Brain Metastasis S Cheok, A Narayan, A Arnal-Estape, A Patel, D Nguyen, V Chiang Neuro-oncology Advances 2 (Suppl 2), ii6, 2020 | 2 | 2020 |
| Circulating tumor DNA (ctDNA) to monitor treatment response and progression in patients treated with tyrosine kinase inhibitors (TKIs) and immunotherapy for EGFR-mutant non … BS Henick, SB Goldberg, A Narayan, C Rossi, S Rodney, AJ Kole, ... Journal of Clinical Oncology 35 (15_suppl), e20652-e20652, 2017 | 1 | 2017 |
| Detection of sensitizing and resistance EGFR mutations from circulating tumor DNA (ctDNA) in blood using multiplexed next-generation sequencing in patients with advanced … SB Goldberg, A Narayan, NJ Carriero, R Nemati, A Bommakanti, A Wurtz, ... Journal of Clinical Oncology 32 (15_suppl), 8093-8093, 2014 | 1 | 2014 |
| Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly (ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors Y Hu, A Narayan, Y Xu, J Wolfe, D Vu, T Trinh, C Kantak, SP Ivy, JP Eder, ... JCO Precision Oncology 8, e2300289, 2024 | | 2024 |
| Dynamics of circulating tumor DNA in patients with advanced solid tumors treated with cediranib and olaparib. Y Hu, A Narayan, J Wolfe, D Vu, T Thi, C Kantak, SP Ivy, JP Eder, ... Journal of Clinical Oncology 39 (15_suppl), 3035-3035, 2021 | | 2021 |
| Detection of Glioma and Prognostic Subtypes by Noninvasive Circulating Cell-Free DNA Methylation Markers S Cheok, A Arnal-Estape, A Narayan | | 2019 |
| META RNA profiling: Multiplexed quantitation of targeted RNAs across large numbers of samples A Narayan, R Johnkennedy, M Zakaria, V Lee, AA Patel Methods 152, 41-47, 2019 | | 2019 |
Kirti SharmaSenior Director, Kymera Therapeutics, Cambridge, MA 02139Dirección de correo verificada de kymeratx.com
